The highly respected Cochrane Collaboration is in crisis today at its 25th annual meeting in Edinburgh as one board member is expelled and six more resign. There are more links below but it seems to have been over a dispute regarding the independence of authors and members with regards to links to industry and pharmaceutical companies.
ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Thoracic Guidelines
September 16, 2018
May 19, 2018
Enhanced recovery programs are very popular now, but their benefits have been mostly theoretical. This article describes challenges and outcomes after initiation of such a program, citing decreased costs, lower opioid usage, and shortened length of stay.
March 31, 2016
The fourth (re- )classification of cardiopericardial tumours came from the World Health Organisation last year, 11 years after the third. In particular, the malignant fibrous histiocytomas are re classified as undifferentiated pleomorphic sarcomas.
July 23, 2015
The paper presents the guidelines for authors on statistical and data reporting for the European Journal of Cardio-Thoracic Surgery (EJCTS) and the Interactive CardioVascular and Thoracic Surgery (ICVTS). It focusses on issues which are most frequently commented on by the statistical reviewers.
June 16, 2015
The British Thoracic Society developed guidelines for evaluation and management of solitary pulmonary nodules based on a literature review and expert opinion. New features include the use of a malignancy risk algorithm, use of a higher threshold for follow-up (5mm), and a reduction in the follow-up interval to 1 year for solid nodules. Management o
November 11, 2014
CMS determined that the evidence of benefit for CT screening for lung cancer is sufficient to permit this as an annual benefit for Medicare and Medicaid recipients in the US. The availability of such coverage will be limited, however, by the need to have the screening as part of a comprehensive counseling (smoking cessation, etc) visit with qualifie
November 5, 2014
The authors examined cost-effectiveness in the National Lung Screening Trial (NLST), examining incremental cost-effectiveness ratio (ICER) and quality-adjusted life years (QALYs) associated with low dose CT screening. The ICER was $52,000 per life-year gained and the $81,000 per QALY gained. These values were very sensitive to variations in the scr
August 2, 2014
2014 consensus guidelines on the perioperative evaluation and management of patients undergoing NONCARDIAC surgery.
July 26, 2014
This article presents guidelines on the diagnosis and management of advanced stage lung cancer developed by the ESMO in 2013.
July 26, 2014
This article summarizes consensus guidelines for the diagnosis and management of early stage lung cancer developed by ESMO in 2013.